TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sana Pharma Sverige AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
5,005
|
4,296
|
4,632 |
| Financial expenses |
9
|
7
|
1 |
| Earnings before taxes |
-890
|
99
|
-2 |
| EBITDA |
-864
|
120
|
17 |
| Total assets |
10,619
|
6,707
|
2,372 |
| Current assets |
10,588
|
6,698
|
2,350 |
| Current liabilities |
9,952
|
6,439
|
2,205 |
| Equity capital |
668
|
268
|
168 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
5
|
4
|
4 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
6.3%
|
4.0%
|
7.1% |
| Turnover per employee |
1,001
|
1,074
|
1,158 |
| Profit as a percentage of turnover |
-17.8%
|
2.3%
|
0.0% |
| Return on assets (ROA) |
-8.3%
|
1.6%
|
0.0% |
| Current ratio |
106.4%
|
104.0%
|
106.6% |
| Return on equity (ROE) |
-133.2%
|
36.9%
|
-1.2% |
| Change turnover |
851
|
-359
|
2,699 |
| Change turnover % |
20%
|
-8%
|
140% |
| Chg. No. of employees |
1
|
0
|
1 |
| Chg. No. of employees % |
25%
|
0%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.